Global Cancer Supportive Care Medicine Market Research Report 2019

Table of Contents

Executive Summary

1 Cancer Supportive Care Medicine Market Overview

• 1.1 Product Overview and Scope of Cancer Supportive Care Medicine
• 1.2 Cancer Supportive Care Medicine Segment by Type
  • 1.2.1 Global Cancer Supportive Care Medicine Production Growth Rate Comparison by Type (2014-2025)
  • 1.2.2 Antiemetic Drugs
  • 1.2.3 Erythropoietin-Stimulating Agents
  • 1.2.4 Granulocyte-Stimulating Agents
  • 1.2.5 Analgesics
  • 1.2.6 Others
• 1.3 Cancer Supportive Care Medicine Segment by Application
  • 1.3.1 Cancer Supportive Care Medicine Consumption Comparison by Application (2014-2025)
  • 1.3.2 Chemotherapy-Induced Anemia
  • 1.3.3 CINV
  • 1.3.4 Bone Metastasis
  • 1.3.5 Cancer Pain
  • 1.3.6 Other
• 1.3 Global Cancer Supportive Care Medicine Market by Region
  • 1.3.1 Global Cancer Supportive Care Medicine Market Size Region
  • 1.3.2 North America Status and Prospect (2014-2025)
  • 1.3.3 Europe Status and Prospect (2014-2025)
  • 1.3.4 China Status and Prospect (2014-2025)
  • 1.3.5 Japan Status and Prospect (2014-2025)
  • 1.3.6 Southeast Asia Status and Prospect (2014-2025)
  • 1.3.7 India Status and Prospect (2014-2025)
• 1.4 Global Cancer Supportive Care Medicine Market Size
  • 1.4.1 Global Cancer Supportive Care Medicine Revenue (2014-2025)
  • 1.4.2 Global Cancer Supportive Care Medicine Production (2014-2025)

2 Global Cancer Supportive Care Medicine Market Competition by Manufacturers

• 2.1 Global Cancer Supportive Care Medicine Production Market Share by Manufacturers (2014-2019)
• 2.2 Global Cancer Supportive Care Medicine Revenue Share by Manufacturers (2014-2019)
• 2.3 Global Cancer Supportive Care Medicine Average Price by Manufacturers (2014-2019)
• 2.4 Manufacturers Cancer Supportive Care Medicine Production Sites, Area Served, Product Types
• 2.5 Cancer Supportive Care Medicine Market Competitive Situation and Trends
  • 2.5.1 Cancer Supportive Care Medicine Market Concentration Rate
  • 2.5.2 Cancer Supportive Care Medicine Market Share of Top 3 and Top 5 Manufacturers
  • 2.5.3 Mergers & Acquisitions, Expansion

3 Global Cancer Supportive Care Medicine Production Market Share by Regions

• 3.1 Global Cancer Supportive Care Medicine Production Market Share by Regions
• 3.2 Global Cancer Supportive Care Medicine Revenue Market Share by Regions (2014-2019)
• 3.3 Global Cancer Supportive Care Medicine Production, Revenue, Price and Gross Margin (2014-2019)
• 3.4 North America Cancer Supportive Care Medicine Production
  • 3.4.1 North America Cancer Supportive Care Medicine Production Growth Rate (2014-2019)
  • 3.4.2 North America Cancer Supportive Care Medicine Production, Revenue, Price and Gross Margin (2014-2019)
• 3.5 Europe Cancer Supportive Care Medicine Production
  • 3.5.1 Europe Cancer Supportive Care Medicine Production Growth Rate (2014-2019)
  • 3.5.2 Europe Cancer Supportive Care Medicine Production, Revenue, Price and Gross Margin (2014-2019)
• 3.6 China Cancer Supportive Care Medicine Production (2014-2019)
  • 3.6.1 China Cancer Supportive Care Medicine Production Growth Rate (2014-2019)
  • 3.6.2 China Cancer Supportive Care Medicine Production, Revenue, Price and Gross Margin (2014-2019)
• 3.7 Japan Cancer Supportive Care Medicine Production (2014-2019)
  • 3.7.1 Japan Cancer Supportive Care Medicine Production Growth Rate (2014-2019)
  • 3.7.2 Japan Cancer Supportive Care Medicine Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Cancer Supportive Care Medicine Consumption by Regions

• 4.1 Global Cancer Supportive Care Medicine Consumption by Regions
• 4.2 North America Cancer Supportive Care Medicine Consumption (2014-2019)
• 4.3 Europe Cancer Supportive Care Medicine Consumption (2014-2019)
• 4.4 China Cancer Supportive Care Medicine Consumption (2014-2019)
• 4.5 Japan Cancer Supportive Care Medicine Consumption (2014-2019)

5 Global Cancer Supportive Care Medicine Production, Revenue, Price Trend by Type

• 5.1 Global Cancer Supportive Care Medicine Production Market Share by Type (2014-2019)
• 5.2 Global Cancer Supportive Care Medicine Revenue Market Share by Type (2014-2019)
• 5.3 Global Cancer Supportive Care Medicine Price by Type (2014-2019)
• 5.4 Global Cancer Supportive Care Medicine Production Growth by Type (2014-2019)

6 Global Cancer Supportive Care Medicine Market Analysis by Applications

• 6.1 Global Cancer Supportive Care Medicine Consumption Market Share by Application (2014-2019)
• 6.2 Global Cancer Supportive Care Medicine Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Cancer Supportive Care Medicine Business

• 7.1 Amgen
  • 7.1.1 Amgen Cancer Supportive Care Medicine Production Sites and Area Served
  • 7.1.2 Cancer Supportive Care Medicine Product Introduction, Application and Specification
  • 7.1.3 Amgen Cancer Supportive Care Medicine Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.1.4 Main Business and Markets Served
• 7.2 Helsinn Healthcare
  • 7.2.1 Helsinn Healthcare Cancer Supportive Care Medicine Production Sites and Area Served
  • 7.2.2 Cancer Supportive Care Medicine Product Introduction, Application and Specification
  • 7.2.3 Helsinn Healthcare Cancer Supportive Care Medicine Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.2.4 Main Business and Markets Served
• 7.3 Johnson &Johnson
  • 7.3.1 Johnson &Johnson Cancer Supportive Care Medicine Production Sites and Area Served
  • 7.3.2 Cancer Supportive Care Medicine Product Introduction, Application and Specification
  • 7.3.3 Johnson &Johnson Cancer Supportive Care Medicine Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.3.4 Main Business and Markets Served
• 7.4 Merck
  • 7.4.1 Merck Cancer Supportive Care Medicine Production Sites and Area Served
  • 7.4.2 Cancer Supportive Care Medicine Product Introduction, Application and Specification
  • 7.4.3 Merck Cancer Supportive Care Medicine Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.4.4 Main Business and Markets Served
• 7.5 F. Hoffmann-La Roche
  • 7.5.1 F. Hoffmann-La Roche Cancer Supportive Care Medicine Production Sites and Area Served
  • 7.5.2 Cancer Supportive Care Medicine Product Introduction, Application and Specification
  • 7.5.3 F. Hoffmann-La Roche Cancer Supportive Care Medicine Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.5.4 Main Business and Markets Served
• 7.6 GlaxoSmithKline
  • 7.6.1 GlaxoSmithKline Cancer Supportive Care Medicine Production Sites and Area Served
  • 7.6.2 Cancer Supportive Care Medicine Product Introduction, Application and Specification
  • 7.6.3 GlaxoSmithKline Cancer Supportive Care Medicine Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.6.4 Main Business and Markets Served
• 7.7 Heron Therapeutics
  • 7.7.1 Heron Therapeutics Cancer Supportive Care Medicine Production Sites and Area Served
  • 7.7.2 Cancer Supportive Care Medicine Product Introduction, Application and Specification
  • 7.7.3 Heron Therapeutics Cancer Supportive Care Medicine Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.7.4 Main Business and Markets Served
• 7.8 Kyowa Hakko Kirin
  • 7.8.1 Kyowa Hakko Kirin Cancer Supportive Care Medicine Production Sites and Area Served
  • 7.8.2 Cancer Supportive Care Medicine Product Introduction, Application and Specification
  • 7.8.3 Kyowa Hakko Kirin Cancer Supportive Care Medicine Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.8.4 Main Business and Markets Served
• 7.9 Novartis
  • 7.9.1 Novartis Cancer Supportive Care Medicine Production Sites and Area Served
  • 7.9.2 Cancer Supportive Care Medicine Product Introduction, Application and Specification
  • 7.9.3 Novartis Cancer Supportive Care Medicine Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.9.4 Main Business and Markets Served
• 7.10 TESARO
  • 7.10.1 TESARO Cancer Supportive Care Medicine Production Sites and Area Served
  • 7.10.2 Cancer Supportive Care Medicine Product Introduction, Application and Specification
  • 7.10.3 TESARO Cancer Supportive Care Medicine Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.10.4 Main Business and Markets Served
• 7.11 Teva Pharmaceutical Industries

8 Cancer Supportive Care Medicine Manufacturing Cost Analysis

• 8.1 Cancer Supportive Care Medicine Key Raw Materials Analysis
  • 8.1.1 Key Raw Materials
  • 8.1.2 Price Trend of Key Raw Materials
  • 8.1.3 Key Suppliers of Raw Materials
• 8.2 Proportion of Manufacturing Cost Structure
• 8.3 Manufacturing Process Analysis of Cancer Supportive Care Medicine
• 8.4 Cancer Supportive Care Medicine Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

• 9.1 Marketing Channel
  • 9.1.1 Direct Marketing
  • 9.1.2 Indirect Marketing
• 9.2 Cancer Supportive Care Medicine Distributors List
• 9.3 Cancer Supportive Care Medicine Customers

10 Market Dynamics

• 10.1 Market Trends
• 10.2 Opportunities
• 10.3 Market Drivers
• 10.4 Challenges
• 10.5 Influence Factors

11 Global Cancer Supportive Care Medicine Market Forecast

• 11.1 Global Cancer Supportive Care Medicine Production, Revenue Forecast
  • 11.1.1 Global Cancer Supportive Care Medicine Production Growth Rate Forecast (2019-2025)
  • 11.1.2 Global Cancer Supportive Care Medicine Revenue and Growth Rate Forecast (2019-2025)
  • 11.1.3 Global Cancer Supportive Care Medicine Price and Trend Forecast (2019-2025)
• 11.2 Global Cancer Supportive Care Medicine Production Forecast by Regions (2019-2025)
  • 11.2.1 North America Cancer Supportive Care Medicine Production, Revenue Forecast (2019-2025)
  • 11.2.2 Europe Cancer Supportive Care Medicine Production, Revenue Forecast (2019-2025)
  • 11.2.3 China Cancer Supportive Care Medicine Production, Revenue Forecast (2019-2025)
  • 11.2.4 Japan Cancer Supportive Care Medicine Production, Revenue Forecast (2019-2025)
• 11.3 Global Cancer Supportive Care Medicine Consumption Forecast by Regions (2019-2025)
  • 11.3.1 North America Cancer Supportive Care Medicine Consumption Forecast (2019-2025)
  • 11.3.2 Europe Cancer Supportive Care Medicine Consumption Forecast (2019-2025)
  • 11.3.3 China Cancer Supportive Care Medicine Consumption Forecast (2019-2025)
  • 11.3.4 Japan Cancer Supportive Care Medicine Consumption Forecast (2019-2025)
• 11.4 Global Cancer Supportive Care Medicine Production, Revenue and Price Forecast by Type (2019-2025)
• 11.5 Global Cancer Supportive Care Medicine Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List